{"id":"https://openalex.org/W4389029549","doi":"https://doi.org/10.1093/ofid/ofad500.1419","title":"1584. Retrospective Study Comparing the Rate of HIV Blips With Combined Antiretroviral Therapy","display_name":"1584. Retrospective Study Comparing the Rate of HIV Blips With Combined Antiretroviral Therapy","publication_year":2023,"publication_date":"2023-11-27","ids":{"openalex":"https://openalex.org/W4389029549","doi":"https://doi.org/10.1093/ofid/ofad500.1419"},"language":"en","primary_location":{"id":"doi:10.1093/ofid/ofad500.1419","doi":"https://doi.org/10.1093/ofid/ofad500.1419","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofad500.1419","pdf_url":"https://academic.oup.com/ofid/article-pdf/10/Supplement_2/ofad500.1419/53768949/ofad500.1419.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://academic.oup.com/ofid/article-pdf/10/Supplement_2/ofad500.1419/53768949/ofad500.1419.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031565682","display_name":"Jennifer Makhoul","orcid":"https://orcid.org/0000-0002-8493-5713","observed_orcids":["https://orcid.org/0000-0002-8493-5713"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Makhoul","raw_affiliation_strings":["UTH Houston/MD Anderson , Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UTH Houston/MD Anderson , Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054130466","display_name":"Surabhi Uppal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I86755215","display_name":"MedStar Health","ror":"https://ror.org/05atemp08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I86755215"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Surabhi Uppal","raw_affiliation_strings":["Medstar Shah Medical Group , Oxon Hill, MD, washington, District of Columbia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medstar Shah Medical Group , Oxon Hill, MD, washington, District of Columbia","institution_ids":["https://openalex.org/I86755215"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113055036","display_name":"Anne A Barnes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I193531525","display_name":"George Washington University","ror":"https://ror.org/00y4zzh67","country_code":"US","type":"education","lineage":["https://openalex.org/I193531525"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anne A Barnes","raw_affiliation_strings":["George Washington University , Washington, District of Columbia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"George Washington University , Washington, District of Columbia","institution_ids":["https://openalex.org/I193531525"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021333270","display_name":"Logan A Werner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Logan A Werner","raw_affiliation_strings":["GW SMHS , merrick, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GW SMHS , merrick, New York","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077198591","display_name":"Gary Leonard Simon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I193531525","display_name":"George Washington University","ror":"https://ror.org/00y4zzh67","country_code":"US","type":"education","lineage":["https://openalex.org/I193531525"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary Simon","raw_affiliation_strings":["The George Washington University , Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The George Washington University , Washington, DC","institution_ids":["https://openalex.org/I193531525"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011450860","display_name":"Marc Siegel","orcid":"https://orcid.org/0000-0001-9029-8389","observed_orcids":["https://orcid.org/0000-0001-9029-8389"]},"institutions":[{"id":"https://openalex.org/I193531525","display_name":"George Washington University","ror":"https://ror.org/00y4zzh67","country_code":"US","type":"education","lineage":["https://openalex.org/I193531525"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marc O Siegel","raw_affiliation_strings":["George Washington University School of Medicine and Health Sciences , Washington, District of Columbia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"George Washington University School of Medicine and Health Sciences , Washington, District of Columbia","institution_ids":["https://openalex.org/I193531525"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3676,"currency":"USD","value_usd":3676},"apc_paid":{"value":3676,"currency":"USD","value_usd":3676},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.22414532,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"Supplement_2","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.875,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.875,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.06780000030994415,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.04839999973773956,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/low-level-viremia","display_name":"low-level viremia","score":0.824999988079071},{"id":"https://openalex.org/keywords/hiv-viral-load","display_name":"HIV viral load","score":0.7549999952316284},{"id":"https://openalex.org/keywords/highly-active-antiretroviral-therapy","display_name":"highly active antiretroviral therapy","score":0.8700000047683716},{"id":"https://openalex.org/keywords/bictegravir-emtricitabine-tenofovir-alafenamide","display_name":"bictegravir/emtricitabine/tenofovir alafenamide","score":0.9810000061988831},{"id":"https://openalex.org/keywords/integrase-inhibitors","display_name":"integrase inhibitors","score":0.765999972820282}],"concepts":[{"id":"https://openalex.org/C2779778239","wikidata":"https://www.wikidata.org/wiki/Q422604","display_name":"Emtricitabine","level":5,"score":0.8485545516014099},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8217558264732361},{"id":"https://openalex.org/C2778723075","wikidata":"https://www.wikidata.org/wiki/Q421547","display_name":"Rilpivirine","level":5,"score":0.7892733812332153},{"id":"https://openalex.org/C2779502633","wikidata":"https://www.wikidata.org/wiki/Q937224","display_name":"Dolutegravir","level":5,"score":0.7868431806564331},{"id":"https://openalex.org/C2911190787","wikidata":"https://www.wikidata.org/wiki/Q22075912","display_name":"Tenofovir alafenamide","level":5,"score":0.7402546405792236},{"id":"https://openalex.org/C2779465607","wikidata":"https://www.wikidata.org/wiki/Q304330","display_name":"Abacavir","level":5,"score":0.6321398019790649},{"id":"https://openalex.org/C2776185481","wikidata":"https://www.wikidata.org/wiki/Q1425304","display_name":"Viremia","level":3,"score":0.6204522848129272},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5561509728431702},{"id":"https://openalex.org/C2777869810","wikidata":"https://www.wikidata.org/wiki/Q422631","display_name":"Lamivudine","level":4,"score":0.5529025197029114},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.49987030029296875},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.48372843861579895},{"id":"https://openalex.org/C2779344132","wikidata":"https://www.wikidata.org/wiki/Q155954","display_name":"Tenofovir","level":3,"score":0.4292856752872467},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.3938516676425934},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3349364995956421},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3312684893608093},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.07219007611274719},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/ofid/ofad500.1419","doi":"https://doi.org/10.1093/ofid/ofad500.1419","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofad500.1419","pdf_url":"https://academic.oup.com/ofid/article-pdf/10/Supplement_2/ofad500.1419/53768949/ofad500.1419.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10678617","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10678617","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10678617/pdf/ofad500.1419.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infect Dis","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/ofid/ofad500.1419","doi":"https://doi.org/10.1093/ofid/ofad500.1419","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofad500.1419","pdf_url":"https://academic.oup.com/ofid/article-pdf/10/Supplement_2/ofad500.1419/53768949/ofad500.1419.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4389029549.pdf","grobid_xml":"https://content.openalex.org/works/W4389029549.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2762685028","https://openalex.org/W7165820448","https://openalex.org/W2576996625","https://openalex.org/W4389030870","https://openalex.org/W7163679151","https://openalex.org/W4392517286","https://openalex.org/W4200500062","https://openalex.org/W4409769730","https://openalex.org/W7168359804","https://openalex.org/W2114192794"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"With":[2],"the":[3,70,200,218,230,247,295,301],"advancement":[4],"of":[5,11,60,64,72,93,121,131,145,207,221,241,274,297],"combined":[6],"antiretroviral":[7],"therapy":[8],"(ART),":[9],"control":[10],"viral":[12,89,174],"replication":[13],"has":[14],"improved":[15],"so":[16],"that":[17,267],"most":[18],"patients":[19,75,147,151,155,160,194,222],"living":[20],"with":[21,101,223],"HIV":[22,29,88,119,243,307],"(PWH)":[23],"can":[24],"maintain":[25],"undetectable":[26],"viral.":[27],"However,":[28],"blips":[30,73,117,126,132,209,225,275],"(defined":[31],"as":[32,118,169],"non-sustained":[33],"detectable":[34],"low-level":[35],"viremia)":[36],"are":[37,285],"still":[38],"commonly":[39],"encountered":[40],"in":[41,74,98,300,310],"practice.":[42],"Although":[43,199],"these":[44,134],"generally":[45],"do":[46],"not":[47,233],"indicate":[48],"treatment":[49],"failure":[50],"or":[51,82,105,197,281,303],"ART":[52],"resistance,":[53],"their":[54],"clinical":[55],"significance":[56],"remains":[57],"a":[58,173,204],"topic":[59],"debate.":[61],"The":[62,129],"aim":[63],"our":[65,99],"study":[66,248],"is":[67],"to":[68,171,178,212,251,277,287,294,305],"compare":[69],"rate":[71,206],"on":[76,152,156,161,164,237,255,261,269,279],"bictegravir/emtricitabine/tenofovir":[77],"alafenamide":[78,299],"(BIC/FTC/TAF),":[79],"rilpivirine/emtricitabine/tenofovir":[80],"(RPV/FTC/TAF)":[81],"dolutegravir/abacavir/lamivudine":[83],"(DOL/ABC/3TC).":[84],"Methods":[85],"We":[86,113],"analyzed":[87],"load":[90],"(VL)":[91],"data":[92,265],"PWH":[94,268,278],"who":[95],"were":[96,148,166,188,232],"treated":[97],"clinic":[100],"either":[102],"BIC/FTC/TAF,":[103,153],"RPV/FTC/TAF":[104,184,216,256],"DOL/ABC/3TC":[106,165,201,238,270,302],"between":[107,133,193],"3/2017":[108],"and":[109,124,158,183,215,229,257],"10/2021":[110],"for":[111,253,259],"blips.":[112],"defined":[114],"low":[115,227],"level":[116],"VL":[120,308],"51-200":[122],"copies/mL":[123],"high-level":[125,208],"of201-1000":[127],"copies/mL.":[128],"incidence":[130],"regimens":[135],"was":[136,226],"examined":[137],"using":[138],"Chi":[139],"squared":[140],"test.":[141],"Results":[142],"A":[143],"total":[144,219],"324":[146],"included;":[149],"138":[150],"91":[154],"RPV/FTC/TAF,":[157],"95":[159],"DOL/ABC/3TC).":[162],"Patients":[163,236],"over":[167,246],"twice":[168],"likely":[170],"have":[172,271],"blip":[175],"(36%)":[176],"compared":[177,211,250,276],"both":[179],"BIC/FTC/TAF":[180,196,213,280],"(16%,":[181],"p=.0003)":[182],"(14%,":[185],"p=.0004).":[186],"There":[187],"no":[189],"statistically":[190,234],"significant":[191],"differences":[192,231],"taking":[195],"RPV/FTC/TAF.":[198,282],"group":[202],"had":[203,239],"higher":[205,272],"(6.3%)":[210],"(3.6%)":[214],"(4.4%),":[217],"number":[220],"high":[224],"(n=15)":[228],"significant.":[235],"average":[240],"8":[242],"VLs":[244],"checked":[245],"period":[249],"5":[252],"patient":[254,260],"3":[258],"BIC/FTC/TAF.":[262],"Conclusion":[263],"Our":[264],"suggests":[266],"rates":[273],"Additional":[283],"studies":[284],"needed":[286],"determine":[288],"if":[289],"this":[290,311],"might":[291],"be":[292],"due":[293,304],"lack":[296],"tenofovir":[298],"increased":[306],"testing":[309],"population.":[312],"Disclosures":[313],"All":[314],"Authors:":[315],"No":[316],"reported":[317],"disclosures":[318]},"counts_by_year":[],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2023-11-27T00:00:00"}